- Mylan N.V. (MYL) announces the U.S. launch of Desvenlafaxine Extended-release Tablets, 50 mg and 100 mg, a generic version of Pfizer's (PFE) Pristiq, indicated for the treatment of major depressive disorder.
- According to IMS Health, the U.S. market is ~$850M.